Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Jubilant Life Sciences gets USFDA nod for anti-depressive drug

      Jubilant Life Sciences gets USFDA nod for anti-depressive drug

      Ruby Khatun Khatun7 July 2017 1:19 PM IST
      New Delhi: Drug firm Jubilant Life Sciences said its subsidiary has received final approval from the US health regulator for Bupropion Hydrochloride...
      Samsung to offer free of cost equipment to select govt hospitals in Tamil Nadu

      Samsung to offer free of cost equipment to select govt hospitals in Tamil Nadu

      Ruby Khatun Khatun7 July 2017 1:18 PM IST
      Chennai: Korean electronics major Samsung launched in Tamil Nadu its Smart Healthcare programme under which advanced equipment manufactured by it are...
      Price fixation of essential drugs hits profitability: Novartis

      Price fixation of essential drugs hits profitability: Novartis

      Ruby Khatun Khatun7 July 2017 10:04 AM IST
      New Delhi: The fixation of ceiling prices of essential drugs by the pharma pricing regulator NPPA has impacted the profitability of the company, drug...
      Open to changes in new standards for food supplements: FSSAI

      Open to changes in new standards for food supplements: FSSAI

      Ruby Khatun Khatun7 July 2017 9:19 AM IST
      New Delhi: Food regulator FSSAI on Thursday assured the food supplements and nutraceuticals industry that it is open to making changes in the new...
      Reckitt Benckiser cuts sales forecast after cyber attack

      Reckitt Benckiser cuts sales forecast after cyber attack

      Ruby Khatun Khatun7 July 2017 9:13 AM IST
      LONDON: British consumer goods maker Reckitt Benckiser trimmed its sales forecasts on Thursday, becoming one of the first companies to put a cost on a...
      15 medical devices notified as drugs for price regulation: CDSCO

      15 medical devices notified as drugs for price regulation: CDSCO

      Ruby Khatun Khatun6 July 2017 5:17 PM IST
      Through a recent notice, Central Drugs Standard Control Organisation (CDSCO),Directorate General of Health Services, Office of Drugs Controller...
      Narayana Health plans to expand in Maharashtra

      Narayana Health plans to expand in Maharashtra

      Ruby Khatun Khatun6 July 2017 1:07 PM IST
      Mumbai: As part of its growth plans, multi-speciality hospital chain Narayana Health is now looking at expanding in Maharashtra after commencing...
      Googles Landmark DeepMind Health trial violated patient data law: UK Watchdog

      Google's Landmark DeepMind Health trial violated patient data law: UK Watchdog

      Ruby Khatun Khatun6 July 2017 1:07 PM IST
      Bloomberg: A landmark medical trial involving Alphabet Inc.’s DeepMind artificial intelligence division violated British data protection laws, the...
      Shantha Biotechnics cholera vaccine, Shanchol achieves 10 million doses milestone

      Shantha Biotechnics cholera vaccine, Shanchol achieves 10 million doses milestone

      Ruby Khatun Khatun6 July 2017 1:03 PM IST
      Hyderabad: Shantha Biotechnics, the Hyderabad-based affiliate of Sanofi Pasteur (the vaccines division of Sanofi), said it has delivered 10 million...
      Zydus Cadila starts phase II trials of molecule targeting anaemia

      Zydus Cadila starts phase II trials of molecule targeting anaemia

      Ruby Khatun Khatun6 July 2017 1:01 PM IST
      New Delhi: Drug firm Zydus Cadila on Wednesday announced the initiation of a phase II trial of oral small molecule Zyan1 that has been designed for...
      Granules India gets board nod to raise foreign limit to 49 percent

      Granules India gets board nod to raise foreign limit to 49 percent

      Ruby Khatun Khatun6 July 2017 1:00 PM IST
      New Delhi: Drug firm Granules India on Wednesday said its board has approved a proposal to increase the foreign investment limit in the company to 49...
      Lupin launches generic conjunctivitis treatment medicine in US

      Lupin launches generic conjunctivitis treatment medicine in US

      Ruby Khatun Khatun6 July 2017 12:59 PM IST
      New Delhi: Domestic pharma major Lupin Ltd on Wednesday said it has launched in the US market its generic version of Moxifloxacin Hydrochloride...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok